CHEOF (Cochlear) Moat Score: 6/10 (As of Jul. 02, 2026)


CHEOF Cochlear Ltd CHEOF
62 GF Score
Price $81.42
GF Value $219.85
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Cochlear Moat Score?

Cochlear CHEOF 62 Moat Score is 6 as of Jul. 02, 2026. GuruFocus rates CHEOF with a GF Score™ of 62/100 and a GF Value™ of $219.85 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Cochlear ranks better than 95.74% on this metric.

Cochlear has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Cochlear has Narrow Moat: Cochlear Ltd has a strong narrow moat due to its valuable intellectual property and leading position in hearing implants. It benefits from customer loyalty and innovation but faces competition and regulatory challenges.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Cochlear might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Cochlear  (OTCPK:CHEOF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Cochlear Moat Score Related Terms

CHEOF vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Cochlear's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cochlear Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's Moat Score distribution charts can be found below:

* The bar in red indicates where Cochlear's Moat Score falls into.


CHEOF
62GF Score
Cochlear Ltd CHEOF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Cochlear (CHEOF) has a Moat Score of 6 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Cochlear ranks #36 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Cochlear's Moat Score too high?
Cochlear's current Moat Score is 6. Based on the distribution chart, Cochlear ranks #36 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Cochlear has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cochlear's Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cochlear ranks #36 out of 846 companies for Moat Score. This places Cochlear in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Cochlear's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cochlear stock overvalued right now?
Based on GuruFocus' analysis, Cochlear (CHEOF) is currently considered Significantly Undervalued. The stock's GF Value™ is $219.85, compared to a current price of $81.42 — trading 63% below its estimated fair value. The current Moat Score is 6. Cochlear's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Cochlear (CHEOF), the current Moat Score is 6 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cochlear (CHEOF) Overvalued in 2026?

Based on GuruFocus' analysis, Cochlear stock appears to be undervalued. The current stock price of $81.42 is trading 63% below its estimated GF Value™ of $219.85. GuruFocus considers Cochlear to be Significantly Undervalued.

Key valuation signals for CHEOF:

  • Moat Score: 6
  • GF Value™: $219.85 vs. price of $81.42 (63% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the CHEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cochlear Business Description

Address 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
62GF Score

Get the complete analysis for CHEOF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.42
Price
$219.85
GF Value